#Carcinoma

Prashant Deshpande

pradesh1001

Jared Diamond proposed that germs, along guns and steel, have shaped our modern world and current pandemic is a good example. But diseases, apart from germs, have also contributed in

Vivek Subbiah, MD

VivekSubbiah

By popular demand The Top 10 clinical publications in Oncology in 2020 (In no particular order). Some important papers bundled + Additional 5 more papers representing major advances in the

Boston Breast Surgeon

DrTedJames

ABSITE is coming up. I'm posting topics in breast cancer surgery that residents should be familiar with. First is the Z11 trial on sentinel node bx. It's critical to know

Pashtoon Kasi MD, MS

pashtoonkasi

Another agnostic approval.#Pembrolizumab #TMBTMB cutoff >=Though I’m overall very supportive of agnostic approvals overall, not sure if TMB is the same across tissue types. @US_FDA #OncoAlert #PrecisionMedicine https://seekingalpha.com

Shrey Srivastava

BlogShrey

#DDDD $DDDD $LBPS $LOACMRx0518 seems to be the gift that keeps on giving right now!The 'clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer' is fantastic

Dr Cathryn Lewis

cathrynlewis

This will present work from ERICA-SA – Evolving Risk Factors for Cancers in African Populations where I’m a proud collaboratorStudying breast, oesophageal squamous & cervical cancer.Funded by South Africa MRC

Shrey Srivastava

BlogShrey

#DDDD $DDDD $LBPS $LOACA very promising RNS today.Bit by bit analysis below. #DDDD $DDDD $LBPS $LOAC'We have generated additional safety and efficacy data, building on the positive data from both

Wiebke Arlt Birmingham, Yes, Birmingham

WiebkeArlt

#1 New @IMSR_UoB @UoB_IAHR research: Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas: a prospective test validation study – learn all about the #EURINEACT study in this twitter

Shu, RMT

anueru432

This is the third and last addition to my #MSPathJournalReview on #ihcpath from Dr. Bellizzi's @IHC_guy amazing paper: "An Algorithmic Immunohistochemical Approach to Define Tumor Type and Assign Site of

Aaron Ring

aaronmring

Our lab's first paper (https://rdcu.be/b49xK ) is now out at @nature. We found that the cytokine IL-18 can drive potent anti-tumor activity from the innate and adaptive immune system, but that

Avraham Z. Cooper, MD

AvrahamCooperMD

1/15Why does alpha-1 antitrypsin deficiency (A1AT) cause liver disease (e.g. cirrhosis or hepatocellular carcinoma)?I always assumed the mechanism was the same as for lung injury and emphysema, but it's not.

Mike Thompson, MD, PhD, FASCO

mtmdphd

[THREAD] #ClinicalTrials Eligibility [Updated Mar 11, 2020] #ctsm Modernizing Eligibility Criteria for Molecularly Driven #ClinicalTrials [7/20/15] - @EdKimMDLCI et al. JCO @ASCO_pubs http://ow.ly/RGEdG metRCC Clinical Trial Participa

Bishal Gyawali

oncology_bg

This thread is going to be a collection of all my #globaloncology papers, primarily for my own reference to bookmark for quick access but also, just in case, it is

🌈Dr. Frizzle

Swilua

Things I wish I could unlearn that I have learned from my students: an ongoing thread. blowflies have "spongey mouth parts" that they use to suck up blood. you won't

Debbee Hutchinson

DebbeeHutchins1

Moderna & Pfizer/BioNTech are testing mRNA (synthetic RNA)vaccines to be rolled out experimentally on millions of people around the world using synthetic RNA mRNA vaccines are a genetically modified biohack

David Steensma

DavidSteensma

Here’s a thread about the #nucleus… no, Professor Ernest Rutherford, not the atomic nucleus that you discovered with your alpha particles back in 1911. This is about *cell* nuclei and

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.